A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.

Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by ...

Yale researchers have created a new method for simulating “aging-like” chromosome errors in mouse eggs to better understand ...

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have developed some of the first robust laboratory models of a ...

Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced a moderated digital poster presentation at ...

Vinay Prasad, chief of the FDA’s Center for Biologics Evaluation and Research, is planning to publish a paper this month to outline his office’s thinking of accelerating gene editing reviews.

Human egg cells are often prone to chromosomal errors. As women age, the error rate increases sharply - and can contribute to infertility, pregnancy ...

Data demonstrate efficacy and durability of vispa-cel, an allogeneic anti-CD19 CAR-T cell therapy, are on par with autologous CAR-T cell ...

In a significant leap forward for neuroscience, researchers at the University of California, Santa Barbara, have successfully ...

John L. Hennessy is President Emeritus of Stanford University as well as the James F. and Mary Lynn Gibbons Professor of ...